Follow this preprint
Adverse Cardiovascular Complications Following Prescription of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity-Score Matched Cohort Study with Competing Risk Analysis
Jiandong Zhou, Sharen Lee, Ishan Lakhani, Lei Yang, Tong Liu, Yuhui Zhang, Yunlong Xia, Wing Tak Wong, Kelvin King Hei Bao, Ian Chi Kei Wong, View ORCID ProfileGary Tse, View ORCID ProfileQingpeng Zhang
doi: https://doi.org/10.1101/2020.12.21.20248648
Now published in Cardio-Oncology doi: 10.1186/s40959-021-00128-5
Jiandong Zhou
1School of Data Science, City University of Hong Kong, Hong Kong, China
Sharen Lee
2Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration
Ishan Lakhani
2Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration
Lei Yang
3Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
MD PhDTong Liu
3Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
MD PhDYuhui Zhang
4Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
MD PhDYunlong Xia
5Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian, China
MD PhD FACCWing Tak Wong
6School of Life Sciences, Chinese University of Hong Kong, Hong Kong, China
PhDKelvin King Hei Bao
7Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China
MB BChir FRCRIan Chi Kei Wong
8Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong, China
PhDGary Tse
2Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration
3Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
9Kent and Medway Medical School, Canterbury, United Kingdom
MD FRCP FACCQingpeng Zhang
1School of Data Science, City University of Hong Kong, Hong Kong, China
PhD
- Supplementary Appendix[supplements/248648_file03.pdf]
Posted August 19, 2021.
Adverse Cardiovascular Complications Following Prescription of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity-Score Matched Cohort Study with Competing Risk Analysis
Jiandong Zhou, Sharen Lee, Ishan Lakhani, Lei Yang, Tong Liu, Yuhui Zhang, Yunlong Xia, Wing Tak Wong, Kelvin King Hei Bao, Ian Chi Kei Wong, Gary Tse, Qingpeng Zhang
medRxiv 2020.12.21.20248648; doi: https://doi.org/10.1101/2020.12.21.20248648
Now published in Cardio-Oncology doi: 10.1186/s40959-021-00128-5
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (731)
- Anesthesia (215)
- Cardiovascular Medicine (3131)
- Dermatology (266)
- Emergency Medicine (464)
- Epidemiology (13082)
- Forensic Medicine (14)
- Gastroenterology (869)
- Genetic and Genomic Medicine (4902)
- Geriatric Medicine (451)
- Health Economics (757)
- Health Informatics (3091)
- Health Policy (1109)
- Hematology (411)
- HIV/AIDS (975)
- Medical Education (457)
- Medical Ethics (121)
- Nephrology (503)
- Neurology (4671)
- Nursing (248)
- Nutrition (691)
- Oncology (2406)
- Ophthalmology (683)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (311)
- Palliative Medicine (88)
- Pathology (520)
- Pediatrics (1249)
- Primary Care Research (526)
- Public and Global Health (7233)
- Radiology and Imaging (1615)
- Respiratory Medicine (945)
- Rheumatology (463)
- Sports Medicine (403)
- Surgery (520)
- Toxicology (65)
- Transplantation (223)
- Urology (193)